hai Flu Vaccine Conferences | Meetings | Events | Symposiums | ConferenceSeries

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

 

Recommended Conferences for Flu Vaccine

Flu Vaccine


As per available reports FluVaccine involves 10 relevant journals 9 Conferences, 5 Collaborations 33 Media Partners and 267 National symposiums are presently dedicated exclusively to Multivalent Vaccines and about 436 open access articles and 1,445 Conference Proceedings are being published on Flu Vaccine.

Flu Vaccine is an annual vaccination using a vaccine that is specific for a given year to protect against the highly variable influenza virus. Over the recent years, the Flu Vaccine manufactures and market has witnessed double digit growth rate due to fear of an impending pandemic. These days Flu vaccine and vaccination challenges on infants, children, pregnant women and elderly patient is major concern for influenza research. Vaccine innovation and human health researchers try to determine how well flu vaccines work to regularly assess and confirm the value of flu vaccination as a public health intervention in each season. Study results about how well a flu vaccine works can vary based on study design, outcome(s) measured, population studied and the season in which the flu vaccine was studied.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.


Scope and Importance:
Flu is an infectious disease caused by the influenza virus. Influenza is a highly contagious disease affecting almost all mammals and birds. Flu occurs globally with an annual attack rate estimated at 5%–10% in adults and 20%–30% in children. Flu vaccine conferences sets international forum for world renowned experts in the field of influenza vaccines and related issues to report on the latest data and trends associated with current and new influenza vaccines/technologies and their availability/delivery/implementation worldwide.

Flu vaccines are a method of preventing a further flu infection. Traditionally a vaccine contains an attenuated form of the virus but now many vaccine types are available including sub-unit vaccines, DNA vaccines, live vaccines etc. The flu vaccine changes yearly and consists of three or four influenza strains. Most vaccines have been shown to be effective against the virus and this is especially true when the chosen strains and the strain in circulation is a match. The virus is raised in chicken eggs although recent vaccines where the virus has been raised in animal cells have been approved. Current research involves producing a universal Flu vaccine and faster methods to produce influenza vaccines. Currently the flu vaccine is surrounded by many controversies; it is deemed to be a product of marketing and fear mongering, its’ effectiveness is not established and, with vaccine administration and its link to Guillain–Barré syndrome. While most studies say that the vaccine is safe and has negligible side-effects its’ efficacy has come under fire recently. There have been a lack of studies on the vaccine and its effects and the absence of standardized data further advocates the voice of flu vaccine skeptics.

Market Analysis:
Market revenue is forecast to increase at a five-year compound annual growth rate (CAGR) of 8% from 2013 to 2018, totaling nearly $6 billion in 2018. The market is broken down into vaccines, therapeutics, and diagnostic products. The vaccines segment has the largest share of the market, worth an estimated $3.2 billion in 2009. This segment is expected to grow at a CAGR of 5.6% to reach nearly $4.2 billion in 2014.
 

International symposium and workshops

World Vaccine Congress, March 29 – 31, 2016, USA.

18th International Conference on Vaccines and Immunization, February 22 - 23, 2016, France.

New Approaches to Vaccines for Human and Veterinary Tropical Diseases, May 22—26, 2016, South Africa.

List of Best International Conferences:

2nd  Flu Conference 
November 17-19, 2016 San Francisco, USA.

H1N1 & Influenza Vaccines Conference
July 18-20, 2016 Chicago, USA.

11th Vaccines & Vaccination Summit
September  12-14, 2016, Pheonix, USA.

7th Middle East Vaccines & Vaccination Summit
September 28-30, 2015 at Dubai, UAE.

Children Vaccines Congress
October 10-12, 2016 Kuala Lumpur, Malaysia.

13th Asia Pacific Vaccines & Vaccination Summit
November 10-12, 2016 Melbourne, Australia.

4th Bacteriology and Infectious Diseases Congress
May 16-18, 2016 San Antonio, USA.

2nd Infectious Diseases Congress
August 25-27, 2016 Philadelphia, USA.

2nd Parasitology Conferences
August 01-03, 2016 Manchester, UK.

2nd Influenza Conferences
September 12-14, 2016 Berlin, Germany.

European Infectious Diseases Conference
August 1-3, 2016 Frankfurt, Germany.

Trauma & Critical Care Congress
March 07-09, 2016 Madrid, Spain.

Tarvel Medicine and Vaccines Conferences
August 1-2, 2016 Seattle, USA.

2nd Respiratory and Pulmonary Medicine Conference
May 09-10, 2016 Chicago, USA.

2nd Retroviruses and Novel Drugs Conferences
June 30-July 1, 2016 Capetown, South Africa.

4th Immunology Conference
October 24-26, 2016, Chicago, USA.

4th Lung & Respiratory Care Conference
August 01-03, 2016 Manchester, UK.

4th Epidemiology and Public Health Conference
October 03-05, 2016 London, UK.

5th Occupational Health & Safety Conference
June 06-07, 2016 Dallas, USA.

Infection Prevention and Control Conferences
August 1-2, 2016 Frankfurt, Germany.

Relevant Society and Associations

International Society of Vaccines.
American College of Physicians-American Society of Internal Medicine (ACP-ASIM).
Center for Vaccine Awareness and Research, Texas Children's Hospital.
Connecticut Humane Society.
International Society for Antiviral research.
Infectious Diseases Society of America.
European society of virology.
Bill & Melinda Gates Foundation.
Influenza Specialist Group.
International Society for Infectious Diseases.
FLURESP.
Humane Society Silicon Valley.
International Society for Influenza and other Respiratory Virus Disease.
American Society for Microbiology.
American society of virology.
International Vaccine Access Center (IVAC).
National Foundation for Infectious Diseases.
National Medical Association.
National Network for Immunization Information (NNii).
The Japanese Society for Vaccinology.


Companies

Novartis.
Eli Lilly & Co.
Johnson&Johnson.
Flugen.
Sanofi Pasteur.
Sandoz.
Immunomic Therapeutics.
GalaxoSmithKline.
Pfizer.
MedImmune (AstraZeneca).
Dr.Reddy.
Crucell (Janssen Pharmaceutical).
Merck.
Lonza.
Pharmajet.
Emergent BioSolutions.
Ranbaxy.
bioCSL (CSL).
Bharat Biotech.
Indian Immunologicals.
 

This page will be updated regularly.

This page was last updated on November 5, 2024

Conference Series Destinations